Cargando…

Application of Artificial Intelligence to Address Issues Related to the COVID-19 Virus

Artificial intelligence (AI) plays a major role in addressing novel coronavirus 2019 (COVID-19)-related issues and is also used in computer-aided synthesis planning (CASP). AI, including machine learning, is used by artificial neural networks such as deep neural networks and recurrent networks. AI h...

Descripción completa

Detalles Bibliográficos
Autor principal: Senthilraja, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society for Laboratory Automation and Screening. Published by Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958383/
https://www.ncbi.nlm.nih.gov/pubmed/33390088
http://dx.doi.org/10.1177/2472630320983813
_version_ 1784676931884548096
author Senthilraja, M.
author_facet Senthilraja, M.
author_sort Senthilraja, M.
collection PubMed
description Artificial intelligence (AI) plays a major role in addressing novel coronavirus 2019 (COVID-19)-related issues and is also used in computer-aided synthesis planning (CASP). AI, including machine learning, is used by artificial neural networks such as deep neural networks and recurrent networks. AI has been used in activity predictions like physicochemical properties. Machine learning in de novo design explores the generation of fruitful, biologically active molecules toward expected or finished products. Several examples establish the strength of machine learning or AI in this field. AI techniques can significantly improve treatment consistency and decision making by developing useful algorithms. AI is helpful not only in the treatment of COVID-19-infected patients but also for their proper health monitoring. It can track the crisis of COVID-19 at different scales, such as medical, molecular, and epidemiological applications. It is also helpful to facilitate the research on this virus by analyzing the available data. AI can help in developing proper treatment regimens, prevention strategies, and drug and vaccine development. Combination with synthesis planning and ease of synthesis are feasible, and more and more automated drug discovery by computers is expected in the near future to eradicate the COVID-19 virus.
format Online
Article
Text
id pubmed-8958383
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Society for Laboratory Automation and Screening. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-89583832022-03-28 Application of Artificial Intelligence to Address Issues Related to the COVID-19 Virus Senthilraja, M. SLAS Technol Review Artificial intelligence (AI) plays a major role in addressing novel coronavirus 2019 (COVID-19)-related issues and is also used in computer-aided synthesis planning (CASP). AI, including machine learning, is used by artificial neural networks such as deep neural networks and recurrent networks. AI has been used in activity predictions like physicochemical properties. Machine learning in de novo design explores the generation of fruitful, biologically active molecules toward expected or finished products. Several examples establish the strength of machine learning or AI in this field. AI techniques can significantly improve treatment consistency and decision making by developing useful algorithms. AI is helpful not only in the treatment of COVID-19-infected patients but also for their proper health monitoring. It can track the crisis of COVID-19 at different scales, such as medical, molecular, and epidemiological applications. It is also helpful to facilitate the research on this virus by analyzing the available data. AI can help in developing proper treatment regimens, prevention strategies, and drug and vaccine development. Combination with synthesis planning and ease of synthesis are feasible, and more and more automated drug discovery by computers is expected in the near future to eradicate the COVID-19 virus. Society for Laboratory Automation and Screening. Published by Elsevier Inc. 2021-04 2022-03-28 /pmc/articles/PMC8958383/ /pubmed/33390088 http://dx.doi.org/10.1177/2472630320983813 Text en Copyright © 2021 Society for Laboratory Automation and Screening. Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review
Senthilraja, M.
Application of Artificial Intelligence to Address Issues Related to the COVID-19 Virus
title Application of Artificial Intelligence to Address Issues Related to the COVID-19 Virus
title_full Application of Artificial Intelligence to Address Issues Related to the COVID-19 Virus
title_fullStr Application of Artificial Intelligence to Address Issues Related to the COVID-19 Virus
title_full_unstemmed Application of Artificial Intelligence to Address Issues Related to the COVID-19 Virus
title_short Application of Artificial Intelligence to Address Issues Related to the COVID-19 Virus
title_sort application of artificial intelligence to address issues related to the covid-19 virus
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958383/
https://www.ncbi.nlm.nih.gov/pubmed/33390088
http://dx.doi.org/10.1177/2472630320983813
work_keys_str_mv AT senthilrajam applicationofartificialintelligencetoaddressissuesrelatedtothecovid19virus